Changes in pelvic and systemic platinum concentrations during negative-balance isolated pelvic perfusion: correlation between platinum concentration and method of administration in a pig model

[1]  H. Wanebo,et al.  Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique , 1996, Annals of Surgical Oncology.

[2]  Y. Kondo,et al.  Reduction of drug leakage by negative-balance isolated pelvic perfusion: correlation between leakage and in-out flow rate in a pig model , 2005, Journal of Cancer Research and Clinical Oncology.

[3]  H. Wanebo,et al.  Isolated pelvic perfusion: plasma pharmacokinetics depend primarily on drug dosage and not the type of drug , 2005, Cancer Chemotherapy and Pharmacology.

[4]  H. Wanebo,et al.  Isolated chemotherapeutic perfusion of the pelvis for advanced rectal cancer , 2003, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[5]  H. Wanebo,et al.  A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion , 1999, Cancer Chemotherapy and Pharmacology.

[6]  K. Aigner,et al.  Pharmacokinetics of Mitomycin C in Pelvic Stopflow Infusion and Hypoxic Pelvic Perfusion with and without Hemofiltration: A Pilot Study of Patients with Recurrent Unresectable Rectal Cancer , 1998, Journal of clinical pharmacology.

[7]  H. Wanebo,et al.  Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. , 1993, Archives of surgery.

[8]  A. Wile,et al.  Hyperthermic pelvic isolation-perfusion in the treatment of refractory pelvic cancer. , 1987, Archives of surgery.

[9]  E. Stemmer,et al.  Pharmacokinetics of 5-fluorouracil during hyperthermic pelvic isolation-perfusion. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J M Collins,et al.  Pharmacologic rationale for regional drug delivery. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  M. Slavik,et al.  Chemotherapy of cancer , 1977 .

[12]  H. Randall,et al.  Regional perfusion of pelvis and abdomen by an indirect technique , 1963, Acta - Unio Internationalis Contra Cancrum.

[13]  P. Kuehn,et al.  Regional perfusion of the pelvis: consideration of the "leakage" problem. , 1961, Surgery.

[14]  E. Watkins,et al.  The use of intravascular balloon catheters for isolation of the pelvic vascular bed during pump-oxygenator perfusion of cancer chemotherapeutic agents. , 1960, Surgery, gynecology & obstetrics.

[15]  R. T. Parker,et al.  Abdominal Perfusion for Cancer Chemotherapy. , 1960, Annals of surgery.

[16]  J. Stehlin,et al.  Regional chemotherapy for cancer: experiences with 116 perfusions. , 1960, Annals of surgery.

[17]  A. Monaco,et al.  Treatment of malignant pelvic tumors by extracorporeal perfusion with chemotherapeutic agents. , 1959, The New England journal of medicine.

[18]  R. F. Ryan,et al.  Chemotherapy of Cancer: Regional Perfusion Utilizing an Extracorporeal Circuit , 1958, Annals of surgery.